(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

FELLOWSHIP IN ANTI - AGING & REGENERATIVE MEDICINE

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

FELLOWSHIP IN ANTI - AGING & REGENERATIVE MEDICINE

ST13

US500000077117099

Class

41

Filing

77117099

Registration

3439027

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

32

Latest update

05/15/2024

Trademark type

Combined

Nice classes

41

Filing date

02/27/2007

Registration date

06/03/2008

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

08/25/2017

Last transaction

05/15/2024

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

First use anywhere

2006-11-00

First use in commerce

2006-11-00

Drawing code

3

Owner type

03

Owner location

Chicago, IL

Examiner

MAYES, LAURIE

Law office

L10

Current location

GENERIC WEB UPDATE

Holders and representatives

Holders

American Board of Anti-Aging & Regenerative Medicine, Inc.

Representatives

Sheryl De Luca Nixon & Vanderhye, P.C.

Technical classification

Nice Classes

Class 41

Vienna Codes

No Vienna codes available.

Goods and services

Class 41

Educational servicesconducting classesseminarsconferencesworkshops in the field of anti-aging regenerative medicine for purposes of certifyingcredentialing and accrediting physicians in these fields; Preparingadminstering and scoring tests for the purpose of certifyingcredentialing and accreditation of physicians in the field of anti-aging regenerative medicine

Publications

History of USPTO decisions and trademark events.

32 publications found

EWAF

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

05/14/2024

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

05/14/2024

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

05/14/2024

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

05/14/2024

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

05/14/2024

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

05/14/2024

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

08/25/2017

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

08/25/2017

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

08/25/2017

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

08/24/2017

E89R

TEAS SECTION 8 & 9 RECEIVED

07/13/2017

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

06/03/2017

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

06/16/2014

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

06/16/2014

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

06/16/2014

E815

TEAS SECTION 8 & 15 RECEIVED

06/02/2014

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

10/04/2012

R.PR

REGISTERED-PRINCIPAL REGISTER

06/03/2008

PUBO

PUBLISHED FOR OPPOSITION

03/18/2008

NPUB

NOTICE OF PUBLICATION

02/27/2008

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

02/08/2008

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

02/08/2008

ACEC

AMENDMENT FROM APPLICANT ENTERED

01/24/2008

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

01/24/2008

ALIE

ASSIGNED TO LIE

01/24/2008

MAIL

PAPER RECEIVED

12/11/2007

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

06/20/2007

GNRT

NON-FINAL ACTION E-MAILED

06/20/2007

CNRT

NON-FINAL ACTION WRITTEN

06/20/2007

DOCK

ASSIGNED TO EXAMINER

06/13/2007

MDSM

NOTICE OF DESIGN SEARCH CODE MAILED

03/03/2007

NWAP

NEW APPLICATION ENTERED

03/02/2007

Continuous trademark protection

Get notified about every new filing that threatens FELLOWSHIP IN ANTI - AGING & REGENERATIVE MEDICINE or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.